EGPI is a pharmaceutical manufacturing company founded in 2006. It began as a sister company to EGD (Egyptian Group for Drug Trading), which started in 1994 as a marketing company. EGPI formulates, registers, and produces high-quality pharmaceutical products. Initially, it focused on the Egyptian market but aims to expand throughout the Middle East.
About EGPI
- Founded in 2006 as a pharmaceutical manufacturing company, subsidiary of EGD.
- Aims to produce high-quality pharmaceutical products initially for the Egyptian market, with plans for expansion in the Middle East.
- Focuses on knowledge transfer, licensing, and technological advancement for mutual benefit.
- Boasts a state-of-the-art Research & Development department with advanced technologies and experienced staff.
- Currently, offers over 150 products across various therapeutic categories and has 10 departments with over 450 employees.
Highlights
- Vision: Aim to be a top pharmaceutical company in Egypt by 2020 and in the Middle East by 2030.
- Mission: Improve lives through high-quality products and introducing value-added solutions.
- Core Values: Committed to making quality healthcare affordable and accessible worldwide.
- Export Market: Prioritizing export sales with a diverse product range targeting various countries.
- Board of Directors: Comprises five key members responsible for the company’s strategic direction.
- Exportation Countries: Currently exporting to Yemen, UAE, Iraq, Palestine, Azerbaijan, and Kazakhstan.
- Future Goals: Aspire to compete globally and expand presence in the international market.
EGPI – Contact Information
Headquarter of EGPI
El Mostakbal Square, El-Shabab St, El Obour City.
CONTACT EGPI
Tel: (+2) 02 43 13 03 21-30
Fax: (+2) 02 43 13 03 24
Email: [email protected]
SCIENTIFIC OFFICE
Address:
Villa 3 Block 7, Gardenia Street, off Street 9, near El Mokattam Club, El Mokattam
Phone:
Phone 1: (+2) 02 28472274 / (+2) 02 28472276
Phone 2: (+2) 02 28472277 / (+2) 02 28472278
Fax: (+2) 02 28472279
Email:
[email protected]
TANTA OFFICE
Address:
The Stadium Area, 13 El-Hana St.
Phone:
Phone: (+2) 040 340 40 26
Phone: (+2) 040 335 04 24
Phone: (+2) 040 334 11 77
Fax: (+2) 040 333 2367
ASSUIT OFFICE
Address:
El-Ebrahemia Towers, Tower 5.
Phone:
Phone: (+2) 088 218 50 51
Phone: (+2) 088 218 50 52
Phone: (+2) 02 24 71 21 15
Fax: (+2) 088 218 50 54
Email:
[email protected]
ALEXANDRIA OFFICE
Address:
36 Roshdy Basha St.
Phone:
Phone: (+2) 03 523 5426
Email:
[email protected]
Notice: Contact details are subject to change. Please confirm the information through additional reliable sources.
For information in Arabic about the company, please visit:
للمعلومات باللغة العربية عن الشركة، يرجى زيارة:
https://www.pharmatop1.com/egpi-contacts/
Product Protofolio
- Alveolin-P Syrup
- Alveolin Syrup
- Cold Control
- Guavaged Syrup
- Aknapalen Gel
- Allerzone ointment, lotion, and cream.
- CLO-BUTRA Cream
- Lamifen Cream
- Lamifen Tablets
- Perfectodil 5% Topical Solution
- Propamethone Cream
- Tazaro 0.1% Gel
Conclusion
In conclusion, EGPI stands as a beacon of excellence in the pharmaceutical industry, driven by a steadfast commitment to innovation, quality, and accessibility in healthcare. With an extensive portfolio of high-quality products, a dedicated team, and a vision for expansion, EGPI continues to revolutionize the healthcare landscape. As they forge ahead, EGPI remains poised to shape the future of healthcare, delivering impactful solutions that improve lives around the world.
Get in Touch with Us
If you have any comments or feedback, please don’t hesitate to contact us. You can also reach us via email ([email protected]) or by using the contact form if you notice any errors on this page or have further information to provide for its update.
Dr. Ahmad Baker, PharmD
Senior Pharmacist & Health Educator
With over 23 years of clinical experience in hospital and community pharmacy across Egypt and Saudi Arabia, Dr. Ahmad specializes in reproductive health and pharmaceutical safety. He is dedicated to providing evidence-based guidance to empower patients in the MENA region.
Medical Disclaimer: This content is for educational purposes and reflects the latest pharmaceutical protocols. It is not a substitute for personal medical advice. Always consult Dr. Ahmad Baker or your healthcare provider before starting any treatment.


